Keywords
diabetes technology
glucose sensors
diabetes self-management
ambulatory glucose profile
cgm
glycemic control
glycemic variability
glycemic stability
hypoglucemia
How to Cite
Abstract
Context: Tools for glucose monitoring at both, capillary and interstitial levels, have evolved in precision and accuracy. Specifically, continuous glucose monitoring systems have made it easier to achieve control goals in patients with diabetes. Although the medical literature recommends that the information obtained from these devices should be organized and summarized, the structured process of interpretation is not standardized.
Objective: To describe from a practical, simple, and intuitive perspective, the interpretation of continuous glucose monitoring system data.
Methodology: A descriptive literature search was performed in the PubMed database and articles relevant to the proposed objectives were selected. Through periodic face-to-face and virtual meetings, a scheme for the interpretation of continuous glucose monitoring records was designed, considering the recommendations of the literature and the personal experience of the authors, to reach a practical consensus.
Results: The interpretation objectives were summarized in 4 steps: 1) Determine if the study is reliable; 2) Define the problem; 3) Determine where the problem is; 4) Identify the etiology of the problem.
Conclusions: Interpretation of data from continuous glucose monitoring systems should be simple, intuitive, and practical.
References
Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83-93. https://doi.org/10.1080/09674845.2012.12002443
Ajjan R, Slattery D, Wright E. Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners. Adv Ther. 2019;36(3):579-96. https://doi.org/10.1007/s12325-019-0870-x
Maiorino MI, Signoriello S, Maio A, Chiodini P, Bellastella G, Scappaticcio L, et al. Effects of Continous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020; 43 (5): 1146 – 56. https://doi.org/10.2337/dc19-1459
Ajjan RA. Diabetes Technol Ther. How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring? Diabetes Technol Ther. 2017 May;19(S2): S27-S36. https://doi.org/10.1089/dia.2017.0021
Wang Y, Zou C, Na H, Zeng W, Li X. Effect of Different Glucose Monitoring Methods on Bold Glucose Control: A Systematic Review and Meta-Analysis. Comput Math Methods Med. 2022 Jun 18; 2022:2851572. https://doi.org/10.1155/2022/2851572
Teo E, Hassan N, Tam W, Koh S. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia. 2022 Apr;65(4):604-619. https://doi.org/10.1007/s00125-021-05648-4
Farhan HA, Bukhari K, Grewal N, Devarasetty S. Use of continuous glucose monitor as a motivational device for lifestyle modifications to improve glycaemic control in patients with type 2 diabetes treated with non-insulin therapies. BMJ Case Rep. 2022 Jun 7;15(6):e248579. https://doi.org/10.1136/bcr-2021-248579
Duarte DB, Fonseca L, Santos T, Silva VB, Marques-Puga F, Saraiva M, et al. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life. Diabetes Metab Syndr. 2022 Jun;16(6):102509. https://doi.org/10.1016/j.dsx.2022.102509
Xiu-Chang VY, Ling-Tan Y, Darryl-Ang WH, Lau Y. Effects of continuous glucose monitoring on maternal and neonatal outcomes in perinatal women with diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2022 Feb; 184:109192. https://doi.org/10.1016/j.diabres.2022.109192
Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017;40(12):1631-40. https://doi.org/10.2337/dc17-1600
Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593-603. https://doi.org/10.2337/dci19-0028
Grunberger G, Sherr J, Allende M, Blevins T, Bode B, Handelsman Y, et al. American Association of Clinica Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons with Diabetes Mellitus. Endocr Pract. 2021 Jun;27(6):505-537. https://doi.org/10.1016/j.eprac.2021.04.008
ElSayed N, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Diabetes Technology: Standards of Medical Care in Diabetes—2023. Diabetes Care 2023 Jan 1;46(Supplement_1):S111-S127. https://doi.org/10.2337/dc23-S007
Bergenstal RM, Simonson GD, Heinemann L. More Green, Less Red: How Color Standardization May Facilitate Effective Use of CGM Data. J Diabetes Sci Technol. 2022 Jan;16(1):3-6. https://doi.org/10.1177/19322968211053341
Ramírez-Rincón A, Tovar-Cortés H, Builes-Montaño CE, Gómez Medina AM, Marín-Sánchez A, Henao-Carrillo DC, et al. Technology in Endocrinology: Stages, Concepts and Implementation. Rev. Colomb Endocrinol Diabet Metab. 2021 Nov. 15;8(1):1-120. https://doi.org/10.53853/encr.8.1.702
Botero JF, Vasquez LM, Blanco VM, Cuesta DP, Ramírez-Rincon A, Bedoya J, et al. The effectiveness of a comprehensive diabetes program for glycemic control and adherence, and the selection of candidates for sensor-augmented insulin pump therapy. Endocrinol Diabetes Nutr (Engl Ed). 2021 Mar 31; S2530-0164(21)00073-2. https://doi.org/10.1016/j.endinu.2020.11.006
Scheiner G. CGM Retrospective Data Analysis. Diabetes Technol Ther. 2016;18(S2): S2-14-S2-22. https://doi.org/10.1089/dia.2015.0281
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet Lond Engl. 1998;352(9131):837-53. https://doi.org/10.1016/S0140-6736(98)07019-6
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up. Diabetes Care. 2016;39(5):686-93. https://doi.org/10.2337/dc15-1990
Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C, Li Z, Brown A, et al. Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care. 2019 Mar;42(3):400-405. https://doi.org/10.2337/dc18-1444
Lu J, Ma X, Zhou J, Zhang L, Mo Y, Ying L, et al. Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes. Diabetes Care. 2018 Nov;41(11):2370-2376. https://doi.org/10.2337/dc18-1131
Lu J, Wang C, Shen Y, Chen L, Zhang L, Cai J, et al. Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care. 2021 Feb;44(2):549-555. https://doi.org/10.2337/dc20-1862
Runge SA, Kennedy L, Brown AS, Dove AE, Levine BJ, Koontz et al. Does Time-in-Range Matter? Perspectives From People with Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes. Clin Diabetes. 2018 Apr;36(2):112-119. https://doi.org/10.2337/cd17-0094
Ajjan R, Slattery D, Wright E. Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners. Adv Ther. 2019;36(3):579-96. https://doi.org/10.1007/s12325-019-0870-x
Xing D, Kollman C, Beck RW, Tamborlane WV, Laffel L, Buckingham BA, et al. Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring. Diabetes Technol Ther. 2011;13(3):351-8. https://doi.org/10.1089/dia.2010.0156
Riddlesworth TD, Beck RW, Gal RL, Connor CG, Bergenstal RM, Lee S, et al. Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control. Diabetes Technol Ther. 2018;20(4):314-6. https://doi.org/10.1089/dia.2017.0455
Vigersky RA, McMahon C. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes. Diabetes Technol Ther. 2019;21(2):81-5. https://doi.org/10.1089/dia.2018.0310
Gómez AM, Henao Carrillo DC, Tapoada L, Rebolledo del Toro M. Relevance of continuous glucose monitoring in clinical practice: review of the evidence. Rev.ACE [Internet]. 2018 Aug. 17 ;5(3):33-42. https://doi.org/10.53853/encr.5.3.432
Borot S, Benhamou PY, Atlan C, Bismuth E, Bonnemaison E, Catargi B, et al. Practical implementation, education, and interpretation guidelines for continuous glucose monitoring: A French position statement. Diabetes Metab. 2017;44(1):61-72. https://doi.org/10.1016/j.diabet.2017.10.009
Chan Juliana CN, Gagliardino JJ, Baik SH, Chantelot JM, Ferreira Sandra RG, Hancu, N, et al. Multifaceted Determinants for Achieving Glycemic Control. The International Diabetes Management Practice Study (IDMPS). Diabetes Care. 2009; 32(2): 227-233. https://doi.org/10.2337/dc08-0435
Bergenstal RM, Beck RW, Close KL, Grunberger G, Sacks D, Kowalski A, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018; 41 (11): 2275 – 80. https://doi.org/10.2337/dc18-1581
Lipska KJ, Warton EM, Huang ES, Moffet HH, Inzucchi SE, Krumholz H, et al. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care. 2013 Nov;36(11):3535-42 https://doi.org/10.2337/dc13-0610
Monnier L, Colette C, Owens D. Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the "Gordian Knot”? Diabetes Metab. 2021 May;47(3):101225. https://doi.org/10.1016/j.diabet.2021.101225
Monnier L, Colette C, Wojtusciszyn A, Dejager S, Renard E, Molinari N, et al. Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes. Diabetes Care. 2017 Jul;40(7):832-838. https://doi.org/10.2337/dc16-1769
International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019 May;7(5):385-396. https://doi.org/10.1016/S2213-8587(18)30315-2
Ceriello A. Targeting one-hour postmeal glucose: is it time for a paradigm switch in diabetes management? Diabetes Technol Ther 2017; 19(9):493–97. https://doi.org/10.1089/dia.2017.0135
Ceriello A, Colagiuri S, Gerich J, Tuomilehto J. Guideline for management of postmeal glucose. Nutr Metab Cardiovasc Dis 2008; 18(4): S17–33. https://doi.org/10.1016/j.numecd.2008.01.012
Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019 Mar;7(3):221-230. https://doi.org/10.1016/S2213-8587(18)30136-0
Saisho Y. Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease? Int J Mol Sci. 2014 Oct; 15(10): 18381–18406. https://doi.org/10.3390/ijms151018381
Kröger J, Reichel A, Siegmund T, Ziegler R. Clinical Recommendations for the Use of the Ambulatory Glucose Profile in Diabetes Care. J Diabetes Sci Technol. 2020 May;14(3):586-594. https://doi.org/10.1177/1932296819883032
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Revista Colombiana de Endocrinología, Diabetes & Metabolismo